Mohammad Asim discusses the use of choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target episode artwork

EPISODE · Apr 1, 2016 · 10 MIN

Mohammad Asim discusses the use of choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target

from The JNCI Podcast · host Oxford University Press

Mohammad Asim discusses the use of choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target

Episode metadata supplied by the publisher feed · Published Apr 1, 2016

Embed this episode

NOW PLAYING

Mohammad Asim discusses the use of choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target

0:00 10:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The JNCI Podcast?

This episode is 10 minutes long.

When was this The JNCI Podcast episode published?

This episode was published on April 1, 2016.

Can I download this The JNCI Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!